We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Expert Opinion / Cases · November 10, 2020

Local Intervention or Systemic Treatment?

Written by
JoAnn Hsu


Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Carlos Dzik

    Nov 11, 2020

    To my experience, Papillary RCC is always a frustrating experience with almost any of those managements from TKIs to IOs. There is no therapy available. So my opinion is local measures almost always. The trick is to find the best timing, always trying to learn the velocity of progression as much as we can, with clinical monitoring and Scans q 3-4 months. The magnitude of distant disease otherwise and location of symptoms or predictability of symptoms is always an important feature to consider.

  • Elchin  Mansurov

    Nov 27, 2020

    Local Intervention + Systemic Treatment(with ICIs)

  • Oct 06, 2022

    Pending Moderator approval.

Further Reading